Under recognition and treatment of lymphedema in head and neck cancer survivors – a database study
Open Access
- 23 March 2023
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 31 (4) , 1-5
Abstract
Purpose: Head and neck cancer (HNC) will be diagnosed in approximately 54,000 Americans in 2022 with more than 11,000 dying as a result. The treatment of HNC often involves aggressive multimodal therapy including surgery, radiotherapy, and systemic therapy. HNC and its treatments are associated with multiple painful and function-limiting neuromusculoskeletal and visceral long-term and late effects. Among these is head and neck lymphedema (HNL), the abnormal accumulation of protein rich fluid, in as many as 90% of survivors. Though HNL is common and potentially contributory to other function-limiting issues in this population, it is notoriously understudied, underrecognized, underdiagnosed, and undertreated. This study seeks to determine the incidence of HNC-related lymphedema diagnosis and treatment in a large US healthcare claims repository database. Methods: A retrospective observational cohort design and data from an integrated US healthcare claims repository—the IBM MarketScan Commercial Claims and Encounters (CCAE) and Medicare Supplemental and Coordination of Benefits (MDCR) Databases spanning the period April 1, 2012 through March 31, 2020. Results: Of the 16,654 HNC patients eligible for evaluation, 1,082 (6.5%) with a diagnosis of lymphedema were identified based on eligibility criteria. Of the 521 HNC patients evaluated for lymphedema treatment, 417 (80.0%) patients received 1.5 courses of MLD, 71 (13.6%) patients were prescribed compression garments, and 45 (8.6%) patients received an advanced pneumatic compression device. Conclusion: HNL in this population of HNC survivors was underdiagnosed and treated compared with contemporary assessments HNL incidence.Keywords
All Related Versions
Funding Information
- Tactile Medical
This publication has 28 references indexed in Scilit:
- The impact of early detection and intervention of breast cancer‐related lymphedema: a systematic reviewCancer Medicine, 2016
- Assessment of lymphatic impairment and interstitial protein accumulation in patients with breast cancer treatment‐related lymphedema using CEST MRIMagnetic Resonance in Medicine, 2015
- Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of lifeHead & Neck, 2012
- Prevalence of Secondary Lymphedema in Patients With Head and Neck CancerJournal of Pain and Symptom Management, 2012
- Lymphedema in Patients With Head and Neck CancerOncology Nursing Forum, 2010
- Lymphedema management in head and neck cancerCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2010
- Editorial introductionsCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2010
- Dysphagia in Head and Neck Cancer Patients Treated With Radiation: Assessment, Sequelae, and RehabilitationSeminars in Radiation Oncology, 2009
- Preoperative assessment enables the early diagnosis and successful treatment of lymphedemaCancer, 2008
- Systemic and global toxicities of head and neck treatmentExpert Review of Anticancer Therapy, 2007